Skip to content

Self-management Interventions for Advanced Breast Cancer

Self-management Interventions for Pain in Advanced Breast Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01927081
Enrollment
65
Registered
2013-08-22
Start date
2014-09-30
Completion date
2017-11-20
Last updated
2018-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Breast Cancer Stage IV

Brief summary

The purpose of this research study is to evaluate whether self-management discussion groups are helpful for women with advanced breast cancer who are experiencing pain. The study is looking at the usefulness of two different types of discussion groups, one of which also includes gentle exercise.

Interventions

Participants engage in discussions regarding issues related to coping with advanced cancer and pain

BEHAVIORALgentle exercise

Patients learn gentle exercise and breathing techniques

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosis of Stage IV breast cancer or recurrent metatastic breast cancer * receiving care at Duke Cancer Institute, * life expectancy ≥9 months as estimated by the treating oncologist, * speak and read English, * be at least age 18 * be able to travel to the Duke Cancer Institute

Exclusion criteria

* cognitive impairment as assessed by the 6-item Mini-mental Status Exam, * Karnofsky Performance Rating of \<60 as rated by the oncology provider, an ECOG rating of 0-2 * treatment for serious psychiatric illness (e.g., schizophrenia, severe depression) in the past 6 months, * currently engaged in yoga practice ≥ 1 day per week

Design outcomes

Primary

MeasureTime frameDescription
Feasibility36 monthsFeasibility will be indicated by our ability to meet accrual goals, and by at least 70% of patients attending ≥4 of 8 sessions and providing post-test assessments
Acceptability36 monthsAcceptability will be assessed via participant ratings on a standardized measure of treatment effectiveness/satisfaction, supplemented by exit interview

Secondary

MeasureTime frameDescription
Change in sleep disturbancestudy entry, following completion of the intervention (approximately 3 months), 6 months, and 9 monthsSleep disturbance as assessed by the Pittsburgh Sleep Quality Index
Change in painstudy entry, following completion of the intervention (approximately 3 months), 6 months, and 9 monthspain intensity as assessed by the Brief Pain Inventory
Change in functional capacitystudy entry, following completion of the intervention (approximately 3 months), 6 months, and 9 monthsFunctional capacity assessed using a 6-minute walk test
Change in Psychological distressstudy entry, following completion of the intervention (approximately 3 months), 6 months, and 9 monthsAnxiety and depression assessed using the Hospital Anxiety and Depression Scale
Change in fatiguestudy entry, following completion of the intervention (approximately 3 months), 6 months, and 9 monthsFatigue as assessed by the Brief Fatigue Inventory

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026